PT  - JOURNAL ARTICLE
AU  - Buckley, Rita
ED  - Bone, Henry G.
TI  - Results from the First Two Years of the FREEDOM Trial Extension
DP  - 2011 Sep 01
TA  - MD Conference Express
PG  - 14--15
VI  - 11
IP  - 5
4099  - http://mdc.sagepub.com/content/11/5/14.short
4100  - http://mdc.sagepub.com/content/11/5/14.full
AB  - Fracture REduction Evaluation of Denosumab in Osteoporosis Every 6 Months [FREEDOM; NCT00089791] was a randomized, placebo-controlled, Phase 3 trial designed to test the effect of denosumab on risk of fracture in postmenopausal women during a 3-year follow-up period [Cummings SR et al. N Engl J Med 2009].